Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Nucleic Acids Research|February 18, 2016
Rad18 confers hematopoietic progenitor cell DNA damage tolerance independently of the Fanconi Anemia pathway in vivoYang Yang, Jonathan C Poe, Lisong Yang, et al.Nature Communications|July 6, 2016
A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesisYanzhe Gao, Elizabeth Mutter-Rottmayer, Alicia M Greenwalt, et al.Genes & Cancer|March 16, 2023
VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in <i>KRAS</i>-mutant pancreatic cancerYe S Lee, Jennifer E Klomp, Clint A Stalnecker, et al.Protein Science : a Publication of the Protein Society|March 18, 2025
A synthetic heavy chain variable domain antibody library (VHL) provides highly functional antibodies with favorable developabilityGuiying Pang, Ruixue Wang, Hongxu Yang, et al.JCI Insight|March 28, 2020
Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapyMatthew B Lipner, Xianlu L Peng, Chong Jin, et al.Nucleic Acids Research|October 24, 2024
PCNA-binding activity separates RNF168 functions in DNA replication and DNA double-stranded break signalingYang Yang, Deepika Jayaprakash, Satpal S Jhujh, et al.Research Square|October 27, 2023
Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in GlioblastomaXing Cheng, Jing An, Jitong Lou, et al.Biorxiv : the Preprint Server for Biology|October 31, 2023
Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in GlioblastomaXing Cheng, Jing An, Jitong Lou, et al.Nature Communications|March 4, 2024
Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastomaXing Cheng, Jing An, Jitong Lou, et al.Pageof 2